StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.90−0.06 (-3.06%)

Close on Nov 18, 2026Market cap $151.33MP/E –Yield –

NervGen Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

NervGen Pharma's market cap was $107.53M on Nov 11, 2026, against $301.03M a year earlier. Over the last 3 years it ranged from $85.24M to $393.87M, with a median of $152.13M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$107.53M-72.7%
2025Dec 31, 2025$393.87M+203.1%
2024Dec 31, 2024$129.94M–

More NervGen Pharma figures

See a number that looks wrong?